Bergsagel PL - Search Results

1

Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression.

Kawano Y, Zavidij O, Park J, Moschetta M, Kokubun K, Mouhieddine TH, Manier S, Mishima Y, Murakami N, Bustoros M, Pistofidis RS, Reidy M, Shen YJ, Rahmat M, Lukyanchykov P, Karreci ES, Tsukamoto S, Shi J, Takagi S, Huynh D, Sacco A, Tai YT, Chesi M, Bergsagel PL, Roccaro AM, Azzi J, Ghobrial IM. Kawano Y, et al. Among authors: bergsagel pl. J Clin Invest. 2018 Jun 1;128(6):2487-2499. doi: 10.1172/JCI88169. Epub 2018 May 14. J Clin Invest. 2018. PMID: 29558366 Free PMC article.

2

Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.

Chesi M, Bergsagel PL, Brents LA, Smith CM, Gerhard DS, Kuehl WM. Chesi M, et al. Among authors: bergsagel pl. Blood. 1996 Jul 15;88(2):674-81. Blood. 1996. PMID: 8695815 Free article.

3

Selective expression of one c-myc allele in two human myeloma cell lines.

Kuehl WM, Brents LA, Chesi M, Bergsagel PL. Kuehl WM, et al. Among authors: bergsagel pl. Cancer Res. 1996 Oct 1;56(19):4370-3. Cancer Res. 1996. PMID: 8813127

4

Dysregulation of c-myc in multiple myeloma.

Kuehl WM, Brents LA, Chesi M, Huppi K, Bergsagel PL. Kuehl WM, et al. Among authors: bergsagel pl. Curr Top Microbiol Immunol. 1997;224:277-82. doi: 10.1007/978-3-642-60801-8_29. Curr Top Microbiol Immunol. 1997. PMID: 9308252

5

IgH translocations in multiple myeloma: a nearly universal event that rarely involves c-myc.

Bergsagel PL, Nardini E, Brents L, Chesi M, Kuehl WM. Bergsagel PL, et al. Curr Top Microbiol Immunol. 1997;224:283-7. doi: 10.1007/978-3-642-60801-8_30. Curr Top Microbiol Immunol. 1997. PMID: 9308253

6

The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts.

Chesi M, Nardini E, Lim RS, Smith KD, Kuehl WM, Bergsagel PL. Chesi M, et al. Among authors: bergsagel pl. Blood. 1998 Nov 1;92(9):3025-34. Blood. 1998. PMID: 9787135 Free article.

7

Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma.

Chesi M, Kuehl WM, Bergsagel PL. Chesi M, et al. Among authors: bergsagel pl. Ann Oncol. 2000;11 Suppl 1:131-5. Ann Oncol. 2000. PMID: 10707795 Review.

8

Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma.

Chesi M, Brents LA, Ely SA, Bais C, Robbiani DF, Mesri EA, Kuehl WM, Bergsagel PL. Chesi M, et al. Among authors: bergsagel pl. Blood. 2001 Feb 1;97(3):729-36. doi: 10.1182/blood.v97.3.729. Blood. 2001. PMID: 11157491 Free article.

9

The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells.

Li Z, Zhu YX, Plowright EE, Bergsagel PL, Chesi M, Patterson B, Hawley TS, Hawley RG, Stewart AK. Li Z, et al. Among authors: bergsagel pl. Blood. 2001 Apr 15;97(8):2413-9. doi: 10.1182/blood.v97.8.2413. Blood. 2001. PMID: 11290605 Free article.

10

The enigma of ectopic expression of FGFR3 in multiple myeloma: a critical initiating event or just a target for mutational activation during tumor progression.

Chesi M, Bergsagel PL, Kuehl WM. Chesi M, et al. Among authors: bergsagel pl. Curr Opin Hematol. 2002 Jul;9(4):288-93. doi: 10.1097/00062752-200207000-00005. Curr Opin Hematol. 2002. PMID: 12042702 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters